Evidence map›Paper›PMID 37767033›Full record

ArticleNanoscale advances2023

A rapid synthesis of molecularly imprinted polymer nanoparticles for the extraction of performance enhancing drugs (PIEDs).

Mark V Sullivan, Connor Fletcher, Rachel Armitage, Chester Blackburn, Nicholas W Turner

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mark V SullivanDepartment of Chemistry, Dainton Building, University of Sheffield Brook Hill Sheffield S3 7HF UK mark.sullivan@sheffield.ac.uk n.w.turner@sheffield.ac.uk.ORCID https://orcid.org/0000-0002-1771-8268
Connor FletcherLeicester School of Pharmacy, De Montfort University The Gateway Leicester LE1 9BH UK.
Rachel ArmitageLeicester School of Pharmacy, De Montfort University The Gateway Leicester LE1 9BH UK.ORCID https://orcid.org/0000-0001-5000-8797
Chester BlackburnDepartment of Chemistry, Dainton Building, University of Sheffield Brook Hill Sheffield S3 7HF UK mark.sullivan@sheffield.ac.uk n.w.turner@sheffield.ac.uk.
Nicholas W TurnerDepartment of Chemistry, Dainton Building, University of Sheffield Brook Hill Sheffield S3 7HF UK mark.sullivan@sheffield.ac.uk n.w.turner@sheffield.ac.uk.ORCID https://orcid.org/0000-0002-9380-5291
De Montfort University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is becoming increasingly more significant to detect and separate hormones from water sources, with the development of synthetic recognition materials becoming an emerging field. The delicate nature of biological recognition materials such as the antibodies means the generation of robust viable synthetic alternatives has become a necessity. Molecularly imprinted nanoparticles (NanoMIPs) are an exciting class that has shown promise due the generation of high-affinity and specific materials. While nanoMIPs offer high affinity, robustness and reusability, their production can be tricky and laborious. Here we have developed a simple and rapid microwaveable suspension polymerisation technique to produce nanoMIPs for two related classes of drug targets, Selective Androgen Receptor Modulators (SARMs) and steroids. These nanoMIPs were produced using one-pot microwave synthesis with methacrylic acid (MAA) as the functional monomer and ethylene glycol dimethacrylate (EGDMA) as a suitable cross-linker, producing particles of an approximate range of 120-140 nm. With the SARMs-based nanoMIPs being able to rebind 94.08 and 94.46% of their target molecules (andarine, and RAD-140, respectively), while the steroidal-based nanoMIPs were able to rebind 96.62 and 96.80% of their target molecules (estradiol and testosterone, respectively). The affinity of nanoMIPs were investigated using Scatchard analysis, with

Identifiers

PMID37767033
PMCPMC10521259
OpenAlexW4386236727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.